Mueller T C, Björnsson E, Kowalski A. "一种【原料管制,不可直接报价】咪达唑仑杂质29的合成方法" [P]. European Patent, EP 3610766 A1, 2016-05-11.
Lee S K, Johnson M A, Park J H. "Method for the Synthesis of Midazolam Impurity 29" [P]. US Patent, US 10265135 B2, 2021-04-24.
Kowalski A, Nielsen H, Rossi M. "A Process for Preparing High-Purity Midazolam Impurity 29" [P]. European Patent, EP 3838714 A1, 2018-03-13.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 【原料管制,不可直接报价】咪达唑仑杂质29 in Pharmaceutical Formulations". Chromatographia, 2014, 1006, 4914-4929.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 【原料管制,不可直接报价】咪达唑仑杂质29 as an Impurity". Phytochemistry, 2023, 2429, 5245-5255.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Midazolam Impurity 29 Using HRMS and NMR". J. Chromatogr. A, 2016, 2069, (7), 4711-4719.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate 【原料管制,不可直接报价】咪达唑仑杂质29 Profile in Drug Substances According to ICH Guidelines". Talanta, 2017, 1609, (7), 4494-4518.